Market Overview:
The global infectious disease treatment market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infectious diseases, rising demand for novel drugs and therapies, and growing awareness about preventive measures. The global infectious disease treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibacterial drugs, antifungal drugs, antiviral drugs, and other types (including antiparasitic agents and antitubercular agents). Antibacterial drugs are expected to account for the largest share of the global infectious disease treatment market in 2018. This can be attributed to their high usage rates for treating a wide range of infections caused by bacteria.
Product Definition:
Infectious Disease Treatment is the use of medicine to treat an infection. The importance of Infectious Disease Treatment is that it can help a person get better and prevent the infection from spreading.
Antibacterial:
Antibacterial is a drug used to treat bacterial infections. The most common types of bacterial infections are respiratory, urinary, and skin. Antibiotics are mainly used for the treatment of acute as well as chronic infectious diseases. Some antibiotics such as penicillin and cephalosporin can be acquired naturally by the body but many others including tetracycline antibiotics must be administered through prescription by healthcare practitioners.
Antifungal Drugs:
Antifungal drugs are used to treat infections caused by fungi. The most common infectious diseases that require antifungal treatment include athlete's foot, ringworm, and fungal meningitis. Antifungal creams, ointments, sprays or tablets are used for the treatment of onychomycosis (fungal infection of the nail), tinea captis (ringworm) and jock itch.
Application Insights:
Based on application, the global infectious disease treatment market is segmented into hospitals and clinics, retail pharmacies and other stores, and others. Hospitals and clinics held the largest share in 2017 owing to factors such as a large patient base with various diseases that require hospital-based management; increasing prevalence of chronic conditions; presence of leading pharmaceutical companies establishing research centers at hospitals for developing new drugs; availability of advanced healthcare facilities at an affordable cost; government initiatives for improving healthcare infrastructure at the local level.
Retail pharmacies also held a significant share in 2017 due to high product demand from patients seeking medication without medical consultation or diagnosis by self-medication or via internet/phone orders. Internet penetration coupled with rising awareness regarding diseases & their symptoms has led to an increase in online pharmacy sales which subsequently increases market size.
Regional Analysis:
North America dominated the market in 2017 owing to a rise in the prevalence of COVID-19 and other infectious diseases. The region is expected to maintain its dominance over the forecast period due to factors such as favorable reimbursement policies, increasing government funding for R&D, and rising awareness among people about early diagnosis.
Asia Pacific is estimated to be fastest growing regional segment during the forecast period owing to an increase in healthcare expenditure by governments along with private sectors for containing emerging infectious diseases. Moreover, high demand for generic drugs from countries like India & China will further boost growth during the forecast period.
Growth Factors:
- Increasing incidence of infectious diseases: The incidence of infectious diseases is increasing at a rapid pace across the globe. This is primarily owing to the changing lifestyle and environmental conditions. This, in turn, is propelling the demand for infectious disease treatment products and services worldwide.
- Growing awareness about preventive measures: There has been a significant rise in awareness about preventive measures against infectious diseases in recent years. People are now more aware of the need to take necessary precautions to avoid getting infected with deadly viruses or bacteria strains. This is boosting demand for various types of infection treatments globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Infectious Disease Treatment Market Research Report
By Type
Antibacterial, Antifungal Drugs, Antiviral Drugs
By Application
Hospitals & Clinics, Retail Pharmacies
By Companies
Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi, Mylan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Infectious Disease Treatment Market Report Segments:
The global Infectious Disease Treatment market is segmented on the basis of:
Types
Antibacterial, Antifungal Drugs, Antiviral Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Retail Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Roche
- Pfizer
- GlaxoSmithKline
- AstraZeneca
- Novartis
- Sanofi
- Mylan
Highlights of The Infectious Disease Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibacterial
- Antifungal Drugs
- Antiviral Drugs
- By Application:
- Hospitals & Clinics
- Retail Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infectious Disease Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infectious disease treatment is the process of treating an infection with antibiotics.
Some of the key players operating in the infectious disease treatment market are Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi, Mylan.
The infectious disease treatment market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infectious Disease Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infectious Disease Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infectious Disease Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infectious Disease Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infectious Disease Treatment Market Size & Forecast, 2020-2028
4.5.1 Infectious Disease Treatment Market Size and Y-o-Y Growth
4.5.2 Infectious Disease Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibacterial
5.2.2 Antifungal Drugs
5.2.3 Antiviral Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals & Clinics
6.2.2 Retail Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infectious Disease Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infectious Disease Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibacterial
9.6.2 Antifungal Drugs
9.6.3 Antiviral Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals & Clinics
9.10.2 Retail Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibacterial
10.6.2 Antifungal Drugs
10.6.3 Antiviral Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals & Clinics
10.10.2 Retail Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibacterial
11.6.2 Antifungal Drugs
11.6.3 Antiviral Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals & Clinics
11.10.2 Retail Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibacterial
12.6.2 Antifungal Drugs
12.6.3 Antiviral Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals & Clinics
12.10.2 Retail Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibacterial
13.6.2 Antifungal Drugs
13.6.3 Antiviral Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals & Clinics
13.10.2 Retail Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infectious Disease Treatment Market: Competitive Dashboard
14.2 Global Infectious Disease Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Roche
14.3.3 Pfizer
14.3.4 GlaxoSmithKline
14.3.5 AstraZeneca
14.3.6 Novartis
14.3.7 Sanofi
14.3.8 Mylan
